Expression of DLK1 Gene in the Bone Marrow Cells of Patients with Myelodysplastic Syndromes and Its Clinical Significance
- Author:
- No author available
- Journal Title:
- CANCER BIOLOGY & MEDICINE
- Issue:
- 3
- DOI:
- 10.7497/j.issn.2095-3941.2012.03.006
- Key Word:
- DLK1 gene;myelodysplastic syndromes;expression
Abstract： Objective This study aims to investigate the expression of delta-like 1 (DLK1) gene in the bone marrow cells of patients with myelodysplastic syndromes (MDS) and to explore its molecular characteristics for the early diagnosis of MDS.Methods The expression of DLK1 mRNA in the bone marrow cells of cases with MDS, acute myeloid leukemia (AML), and normal control groups were measured by real-time polymerase chain reaction and were analyzed for clinical significance.Results Significantly higher expression of DLK1 mRNA was observed in the bone marrow cells of MDS patients (0.7342±0.3652) compared with the normal control group (0.4801±0.1759) (P<0.05). The expression of DLK1 mRNA had a positive correlation with the proportion of bone marrow blasts (r=0.467, P<0.05). Moreover, DLK1 mRNA expression was significantly increased as MDS progressed (P<0.05). Patients with abnormal karyotypes exhibited significantly higher expression of DLK1 mRNA (0.9007±0.4334) than those with normal karyotypes (0.6411±0.2630) (P<0.05). Subsequently, patients with highly expressed DLK1 (≥0.8) presented significantly higher malignant clone burden (0.4134±0.3999) than those with lower DLK1 expression (<0.8),(0.1517±0.3109), (P<0.05). Conclusions The DLK1 gene was highly expressed in MDS patients, and was increased as MDS progressed. The expression of DLK1 mRNA was positively correlated with the proportion of the bone marrow blasts. A high expression of DLK1 gene suggested a higher malignant clone burden of MDS.
- [1]Sorensen I,Adams RH,Gossler A.DLL1-mediated Notch activation regulates endothelial identity in mouse fetal arteries.[J].2009,113(22).
- [2]Langer F,Tessema M,Stickel J,etc.Overexpression of delta-like (Dlk) in a subset of myelodysplastic syndrome bone marrow trephines.[J].2004,28(10).
- [3]Pear WS,Radtke F,Rebelo M,etc.Notch1 engagement by Delta-like-1 promotes differentiation of B lymphocytes to antibody-secreting cells[J].2007,104(39).
- [4]Bhatia R,Forman SJ,Li L.Expression of DLK1 in hematopoietic cells results in inhibition of differentiation and proliferation.[J].2005,24(27).
- [5]Begum,A.,Lin,Q.,Yun,Z.,etc.DLK1, delta-like 1 homolog (Drosophila), regulates tumor cell differentiation in vivo[J].2012,318(1).
- [6]Hicklin D.,Pytowski B.,Witte L.,etc.Hematopoietic Activity of a Stromal Cell Transmembrane Protein Containing Epidermal Growth Factor-Like Repeat Motifs[J].1997,94(8).
- [7]Miller CW,Kim KH,Hofmann WK,etc.Dlk1 in normal and abnormal hematopoiesis.[J].2005,19(8).
- [8]Laborda J,Boissy P,Dahlgaard J,etc.dlk1/FA1 regulates the function of human bone marrow mesenchymal stem cells by modulating gene expression of pro-inflammatory cytokines and immune response-related factors.[J].2007,282(10).
- [9]You YP,Qian CF,Fu Z,etc.Notch1 induces enhanced expression of Delta-like-1 in the U251MG glioma cell line.[J].2009,24(4).
- [10]Kaneta M,Takahama2 Y,Sudo K,etc.A role for pref-1 and HES-1 in thymocyte development.[J].2000,164(1).
- [11]Liu D,Cen J,Qi X,etc.Expression of Dlk1 gene in myelodysplastic syndrome determined by microarray, and its effects on leukemia cells.[J].2008,22(1).
- [12]Kassem M.Regulation of Human Skeletal Stem Cells Differentiation by Dlk1/Pref-1.[J].2004,19(5).
- [13]Nielsen O,Floridon C,Westergaard JG,etc.Does fetal antigen 1 (FA1) identify cells with regenerative, endocrine and neuroendocrine potentials? A study of FA1 in embryonic, fetal, and placental tissue and in maternal circulation.[J].2000,66(1).
- [14]Greenberg P,Pfeilstocker M,Ruter B,etc.Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: Consensus statements and report from a working conference.[J].2007,31(6).